If the technical working group deems it necessary to update the EU common list, a proposal is submitted to the Health Security Committee for agreement. The technical working group has thus put in place a structured, coherent and swift procedure for assessing the clinical performance of rapid antigen tests that have been validated through independent evaluation studies, resulting in an update of the EU common list at least once a month.
Recital 6, Regulation (EU) 2022/256
In forcesince 22 Feb 2022